EPAS1 and polycythemia: Further, tumors have been associated with EPAS1 mutations, either in the absence or presence of polycythemia, and polycythemia alone is seen in cases with mosaic mutations in EPAS1. Likewise, Buffet and colleagues have reported the presence of mosaic mutations in two patients with HIF-2α-related polycythemia/PGL syndrome (120).